Literature DB >> 25024431

Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.

Julio Cesar Aguila1, Alexandra Blak1, Joris van Arensbergen1, Amaia Sousa1, Nerea Vázquez1, Ariane Aduriz1, Mayela Gayosso1, Maria Paz Lopez Mato1, Rakel Lopez de Maturana1, Eva Hedlund1, Kai-Christian Sonntag1, Rosario Sanchez-Pernaute2.   

Abstract

Human embryonic and induced pluripotent stem cells are potential cell sources for regenerative approaches in Parkinson disease. Inductive differentiation protocols can generate midbrain dopamine neurons but result in heterogeneous cell mixtures. Therefore, selection strategies are necessary to obtain uniform dopamine cell populations. Here, we developed a selection approach using lentivirus vectors to express green fluorescent protein under the promoter region of FOXA2, a transcription factor that is expressed in the floor plate domain that gives rise to dopamine neurons during embryogenesis. We first validated the specificity of the vectors in human cell lines against a promoterless construct. We then selected FOXA2-positive neural progenitors from several human pluripotent stem cell lines, which demonstrated a gene expression profile typical for the ventral domain of the midbrain and floor plate, but failed to enrich for dopamine neurons. To investigate whether this was due to the selection approach, we overexpressed FOXA2 in neural progenitors derived from human pluripotent stem cell lines. FOXA2 forced expression resulted in an increased expression of floor plate but not mature neuronal markers. Furthermore, selection of the FOXA2 overexpressing fraction also failed to enrich for dopamine neurons. Collectively, our results suggest that FOXA2 is not sufficient to induce a dopaminergic fate in this system. On the other hand, our study demonstrates that a combined approach of promoter activation and lentivirus vector technology can be used as a versatile tool for the selection of a defined cell population from a variety of human pluripotent stem cell lines. ©AlphaMed Press.

Entities:  

Keywords:  Cell selection; Dopamine; FACS; Floor plate; Neurogenesis; Promoter

Mesh:

Substances:

Year:  2014        PMID: 25024431      PMCID: PMC4149300          DOI: 10.5966/sctm.2014-0011

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  57 in total

Review 1.  Neural transplantation for the treatment of Parkinson's disease.

Authors:  Anders Björklund; Stephen B Dunnett; Patrik Brundin; A Jon Stoessl; Curt R Freed; Robert E Breeze; Marc Levivier; Marc Peschanski; Lorenz Studer; Roger Barker
Journal:  Lancet Neurol       Date:  2003-07       Impact factor: 44.182

2.  Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells.

Authors:  Yuichi Ono; Tomoya Nakatani; Yoshimasa Sakamoto; Eri Mizuhara; Yasuko Minaki; Minoru Kumai; Akiko Hamaguchi; Miyuki Nishimura; Yoko Inoue; Hideki Hayashi; Jun Takahashi; Toshio Imai
Journal:  Development       Date:  2007-08-01       Impact factor: 6.868

3.  FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate.

Authors:  W Ye; K Shimamura; J L Rubenstein; M A Hynes; A Rosenthal
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

4.  Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

Authors:  Marios Politis; Kit Wu; Clare Loane; Niall P Quinn; David J Brooks; Stig Rehncrona; Anders Bjorklund; Olle Lindvall; Paola Piccini
Journal:  Sci Transl Med       Date:  2010-06-30       Impact factor: 17.956

5.  The human HNF-3 genes: cloning, partial sequence and mutation screening in patients with impaired glucose homeostasis.

Authors:  M A Navas; C Vaisse; S Boger; M Heimesaat; L A Kollee; M Stoffel
Journal:  Hum Hered       Date:  2000 Nov-Dec       Impact factor: 0.444

6.  Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development.

Authors:  Wei Lin; Emmanouil Metzakopian; Yannis E Mavromatakis; Nan Gao; Nikolaos Balaskas; Hiroshi Sasaki; James Briscoe; Jeffrey A Whitsett; Martyn Goulding; Klaus H Kaestner; Siew-Lan Ang
Journal:  Dev Biol       Date:  2009-07-14       Impact factor: 3.582

7.  Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.

Authors:  Rakel Lopez de Maturana; Julio C Aguila; Amaya Sousa; Nerea Vazquez; Patricia Del Rio; Ana Aiastui; Ana Gorostidi; Adolfo Lopez de Munain; Rosario Sanchez-Pernaute
Journal:  Neurobiol Aging       Date:  2013-11-22       Impact factor: 4.673

8.  Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations.

Authors:  Jan Pruszak; Kai-Christian Sonntag; Moe Hein Aung; Rosario Sanchez-Pernaute; Ole Isacson
Journal:  Stem Cells       Date:  2007-06-21       Impact factor: 6.277

9.  Comparison of lentiviral vector titration methods.

Authors:  Martine Geraerts; Sofie Willems; Veerle Baekelandt; Zeger Debyser; Rik Gijsbers
Journal:  BMC Biotechnol       Date:  2006-07-12       Impact factor: 2.563

10.  Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy.

Authors:  Julio C Aguila; Eva Hedlund; Rosario Sanchez-Pernaute
Journal:  Stem Cells Int       Date:  2012-09-04       Impact factor: 5.443

View more
  9 in total

1.  Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.

Authors:  Isabelle R de Luzy; Jonathan C Niclis; Carlos W Gantner; Jessica A Kauhausen; Cameron P J Hunt; Charlotte Ermine; Colin W Pouton; Lachlan H Thompson; Clare L Parish
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

2.  Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms.

Authors:  Kasem Kulkeaw; Alisa Tubsuwan; Nongnat Tongkrajang; Narisara Whangviboonkij
Journal:  PeerJ       Date:  2020-10-19       Impact factor: 2.984

3.  Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.

Authors:  Rakel López de Maturana; Valérie Lang; Amaia Zubiarrain; Amaya Sousa; Nerea Vázquez; Ana Gorostidi; Julio Águila; Adolfo López de Munain; Manuel Rodríguez; Rosario Sánchez-Pernaute
Journal:  J Neuroinflammation       Date:  2016-11-18       Impact factor: 8.322

4.  LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.

Authors:  Garikoitz Azkona; Rakel López de Maturana; Patricia Del Rio; Amaya Sousa; Nerea Vazquez; Amaia Zubiarrain; Daniel Jimenez-Blasco; Juan P Bolaños; Blas Morales; Georg Auburger; José Matias Arbelo; Rosario Sánchez-Pernaute
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

5.  iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology.

Authors:  Andreu Matamoros-Angles; Lucía Mayela Gayosso; Yvonne Richaud-Patin; Angelique di Domenico; Cristina Vergara; Arnau Hervera; Amaya Sousa; Natalia Fernández-Borges; Antonella Consiglio; Rosalina Gavín; Rakel López de Maturana; Isidro Ferrer; Adolfo López de Munain; Ángel Raya; Joaquín Castilla; Rosario Sánchez-Pernaute; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

6.  IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.

Authors:  Daniela Lehnen; Serena Barral; Tiago Cardoso; Shane Grealish; Andreas Heuer; Andrej Smiyakin; Agnete Kirkeby; Jutta Kollet; Harold Cremer; Malin Parmar; Andreas Bosio; Sebastian Knöbel
Journal:  Stem Cell Reports       Date:  2017-09-21       Impact factor: 7.765

7.  Efficient derivation of dopaminergic neurons from SOX1⁻ floor plate cells under defined culture conditions.

Authors:  Mingming Li; Yu Zou; Qiqi Lu; Ning Tang; Alexis Heng; Intekhab Islam; Huei Jinn Tong; Gavin S Dawe; Tong Cao
Journal:  J Biomed Sci       Date:  2016-03-08       Impact factor: 8.410

8.  Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential.

Authors:  Stefania Fedele; Ginetta Collo; Katharina Behr; Josef Bischofberger; Stephan Müller; Tilo Kunath; Klaus Christensen; Anna Lisa Gündner; Martin Graf; Ravi Jagasia; Verdon Taylor
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

Review 9.  Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development.

Authors:  S A Antonov; E V Novosadova
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.